Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.
Gallant
Joel E
JE
D003906:Developing Countries; D024921:Drug Resistance, Multiple, Viral; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology; D019829:Nevirapine / Q000494:pharmacology; D011480:Protease Inhibitors / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use; D018119:Stavudine / Q000494:pharmacology; D017211:Treatment Failure; D019562:Viral Load
D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019829:Nevirapine; D018119:Stavudine